In today’s regulated landscape, Extractables and Leachables (E&Ls) have become a defining aspect of product safety — from Medical Devices and Drug Packaging to Cosmetic Containers and Applicators. These chemical entities may migrate from packaging or device materials into the product. While often present at trace levels, their potential to cause adverse health effects makes them a critical focus of safety evaluation.
A robust Toxicological Risk Assessment (TRA) of extractables and leachables not only ensures regulatory compliance but also safeguards consumer safety and protects brand integrity.
What Are Extractables and Leachables — and Why Their Assessment Matters
Extractables: These are chemical compounds that can be released from packaging material, device components, or manufacturing systems under exaggerated laboratory conditions such as strong solvents or elevated temperatures, or extended contact time.
Leachables: These are chemical compounds that migrate into a product or formulation under normal storage and usage conditions throughout the product’s shelf life.
Why It Matters
Even at trace levels, Extractables and leachables (E&Ls) can compromise product safety, quality, stability, and performance over time. Uncontrolled chemical migration may lead to toxicological risks, altered product efficacy, or regulatory non-compliance.
A structured E&L assessment helps to identify potential contaminants early in product development, supports material selection, and ensures that final products meet global safety and quality standards. Beyond compliance, it strengthens consumer trust and demonstrates a brand’s commitment to scientific integrity and consumer protection.
Regulatory Context in the USA and Europe
1. United States
In the U.S., the Food and Drug Administration (FDA) mandates comprehensive chemical characterization and toxicological assessment of E&Ls for drug products, medical devices, and packaging systems.
FDA expectations are outlined in key references such as:
● USP <1663>/<1664> - Assessment of Extractables and Leachables associated with Pharmaceutical Packaging/Delivery Systems
● ISO 10993 - Standard for Medical Devices
These standards guide the identification, quantification, and toxicological assessment of potential E&Ls to ensure product safety and performance. Documentation must be maintained for both regulatory submissions and quality assurance.
2. Europe
In Europe, regulatory frameworks place equal emphasis on chemical safety, human health protection, and material compatibility.
● The European Medicines Agency (EMA) and European Pharmacopoeia (Ph. Eur.) set strict requirements for extractables and leachables testing in line with ICH Q3E (E&Ls).
● For Medical Devices, the EU Medical Device Regulation (MDR) requires chemical characterization and toxicological evaluation in accordance with ISO 10993.
● E&L documentation forms a key component of dossiers submitted to regulatory authorities during marketing authorization or technical file reviews.
Common Pitfalls
● Incomplete Materials Mapping — Missing a single component leaves unassessed leachables and regulatory gaps.
● Inadequate Threshold Justification — Analytical Evaluation Thresholds (AETs) or safety limits must be scientifically defensible.
● Data Gaps in Toxicology — Many E&Ls are novel, with limited published toxicity data. Assessing safety often requires read-across, predictive modeling, or application of Threshold of Toxicological Concern (TTC), which demand expert judgment.
● Exposure Estimation Complexity — Dose, frequency, duration, and product-contact area must be precise. Small errors can meaningfully alter conclusions.
● Over-reliance on vendor statements — Sometimes, supplier data alone is insufficient without confirmatory testing or risk evaluation.
● Neglecting Cumulative Exposure — Multiple sources can add risk
● Weak documentation — Regulators require traceable, transparent reasoning.
Emerging Trends and Technologies
Modern approaches enhancing the speed, accuracy, and predictive power of toxicological risk assessments for extractables and leachables:
● Predictive Toxicology and In Silico Tools
Read-across, QSAR, and curated toxicology databases help fill data gaps for novel or poorly characterized compounds, supporting faster, defensible safety conclusions and reducing reliance on animal testing.
● Regulatory Convergence
FDA, EMA, USP, and ISO guidance are increasingly aligned, emphasizing structured, risk-based toxicology assessment.
● Predictive Risk Modeling
Integrates data on exposure, chemical properties, and biological activity to forecast potential hazards.
● Centralized Data Management
Digital platforms consolidate analytical results, toxicology data, and regulatory references for faster assessment and reporting.
Emerging trends focus on enhancing expert toxicology assessment through better data, risk frameworks, and regulatory alignment, enabling safer, more defensible E&Ls assessment.
Expert-Led Toxicological Risk Assessment with SciQra
While advanced analytical tools, predictive modeling, and large datasets significantly enhance efficiency, expert judgment remains the cornerstone of a defensible toxicological risk assessment.
SciQra’s Key Service Pillar includes:
➔ End-to-End Safety Assessment
● From dose–response evaluation to exposure assessment and risk characterization, we support every critical step, ensuring that safety conclusions are scientifically robust and traceable.
➔ Regulatory Alignment Across Industries and Regions
● Our assessments are designed to satisfy the expectations of regulators in both the USA and Europe, spanning pharmaceuticals, biologics, and medical devices.
➔ Tailored, Data-Driven Solutions
● We integrate validated databases, peer-reviewed literature, supplier information, and predictive modeling to fill data gaps and provide scientifically defensible assessments.
➔ Analytical rigor
● SciQra employs validated/qualified methods, establishes clear Analytical Evaluation Thresholds (AETs), and ensures robust data reporting.
➔ Toxicological science
● We apply the Threshold of Toxicological Concern (TTC) where appropriate, derive conservative PDE values, and read-across strategies with structure–activity relationship analyses.
➔ Smart Workflow Integration
● Centralized data management, structured reporting, and standardized templates streamline complex assessments, ensuring consistency, traceability, and audit readiness.
By combining expert interpretation with advanced methodologies, scientific precision, and regulatory insight, SciQra transforms E&L data into actionable, defensible conclusions, enables brands to manage extractables and leachables safely and efficiently, protecting consumers and strengthening trust in global markets.
Conclusion
Extractables and leachables present complex challenges in product safety evaluation. Ensuring reliable toxicological risk assessment is essential for regulatory compliance, consumer protection, and brand reputation. Through comprehensive expertise, technological integration, and global regulatory understanding, SciQra empowers companies to achieve reliable, defensible, and efficient extractables and leachables assessments, supporting safe and compliant products across international markets.
Ready to discuss your project? Contact us today and take the next step with confidence.